Exchange: NASDAQ·Updated 03:58 PM EDT
ADMA logo

ADMA Adma Biologics Inc

$9.72
$0.165
(1.73%)
Today
Reported EarningsAug 5
Mkt Cap$2.14B
Vol748,225.00

About ADMA

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.
39

Bearish Sentiment

How do you feel about ADMA?

Advertisement|Remove ads.